Onco-Innovations Announces Amendment to Private Placement Pricing

Executive Summary

• Onco‑Innovations Limited amends its previously announced private placement, now offering up to 3,076,923 units at $0.65 per unit for gross proceeds of up to $2,000,000.
• Each unit consists of one common share and one warrant exercisable at $0.75 per share for three years; an additional 1 % of the shares issued will be allocated as “Admin Fee Shares” to a third‑party facilitator.
• Proceeds are earmarked for general corporate and working‑capital purposes, including research & development and investor‑relations activities.

Key Details

• Units Offered: Up to 3,076,923 units (each = 1 common share + 1 warrant).
• Pricing: $0.65 per unit → $2,000,000 maximum gross proceeds.
• Warrant Terms: Each warrant allows purchase of one share at $0.75, exercisable for three years from issuance.
• Admin Fee Shares: Shares equal to 1 % of the total shares issued will be given to an arm’s‑length third party as compensation for placement assistance.
• Finder’s Fees/Warrants: Company may issue additional finders’ fees or warrants on the same terms to parties introducing subscribers.
• Closing Conditions: Subject to regulatory approvals and other customary conditions; securities subject to a hold period of four months and one day.
• Use of Proceeds: General corporate and working‑capital purposes, including advancement of operational and R&D objectives and investor‑relations activities.
• Regulatory Note: Securities not registered under U.S. law; offering unavailable to U.S. persons absent exemption or registration.

Notable Quotes

“The amended private placement provides us with the capital needed to accelerate our research initiatives and strengthen our financial position,” – Thomas O'Shaughnessy, Chief Executive Officer.